Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1073-1079

  Korbling M ^a   Anderlini, P ^a   Durett, A ^a   Maadani, F ^a   Bojko, P ^a   Seong, D ^a   Giralt, S ^a   Khouri, I ^a   Andersson, B ^a   Mehra, R ^a   VanBesien, K ^a   Mirza, N ^a   Przepiorka, D ^a   Champlin, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Allogeneic blood stem cell transplantation; rhG CSF; Stem cell apheresis; Stem cell mobilization

Indexed keywords

ALKALINE PHOSPHATASE; CD3 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HEMOGLOBIN; LACTATE DEHYDROGENASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOID CELL; MALE; NORMAL HUMAN; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPRESSOR CELL; THROMBOCYTE COUNT;

ADP-RIBOSYL CYCLASE; ALKALINE PHOSPHATASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, THY-1; BLOOD CELL COUNT; FILGRASTIM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; IMMUNOPHENOTYPING; L-LACTATE DEHYDROGENASE; LEUKAPHERESIS; LYMPHOCYTE SUBSETS; MEMBRANE GLYCOPROTEINS; N-GLYCOSYL HYDROLASES; PILOT PROJECTS; PROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030444531     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.
2. dim) and lymphoid subsets, and possible predictors of engraftment and GVHD. Blood 1995; 86: 2842-2848.
3. Bonilla MA, Dale D, Zeidler C et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994; 88: 723-730.
4. Anderlini P, Przepiorka D, Seong D et al. Clinical toxicity and laboratory effects of granulocyte colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996; 36: 590-595.
5. Nicholson IKA, Jones BM, Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using single tube three color assay. Cytometry 1993; 14: 685-689.
6. Durett AG, Rondon G, Dimopoulos M, Hester JP. Three-color phenotype analysis using LYSIS-II software. Proceedings of the International Cytometry Symposium, San Francisco, CA, January 1994.
7. Hunter SD, Peters LE, Wotherspoon JS, Crowe SM. Lymphocyte subset analysis by Boolean algebra: a phenolypical approach using a cocktail of 5 antibodies and 3 color immunofluorescence. Cytometry 1994; 15: 258-266.
8. - subpopulation from mobilized peripheral blood. Blood 1995; 85: 368-378.
9. Weaver CH, Longin K. Buckner CD, Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994; 13: 411-415.
10. Lindemann A, Herrmann F, Oster W et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989; 74: 2644-2651.
11. Kovacs P, Bruch C, Herbst EW, Fliedner TM. Collection of in vitro colony-forming units from dogs by repeated continuous flow leukaphereses. Acta Haematologica 1978; 60: 172-181.
12. Gabrilove JL, Jakubowski A, Fain K et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82: 1454-1461.
13. Martinez C. Urbano-lspizua A, Mazzara R et al. Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects. Blood 1996; 87: 4916-4917.
14. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl J Med 1992; 327: 28-35.
15. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
16. Comenzo RL, Malachowski ME, Miller KB et al. Engraftment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 1989; 32: 2644-2651.
17. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
18. + blood cells. Blood 1996; 87: 4903-4909.
19. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.